BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11710690)

  • 1. Surfactant protein A expression in human normal and neoplastic breast epithelium.
    Braidotti P; Cigala C; Graziani D; Del Curto B; Dessy E; Coggi G; Bosari S; Pietra GG
    Am J Clin Pathol; 2001 Nov; 116(5):721-8. PubMed ID: 11710690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of parathyroidlike protein in normal, proliferative, and neoplastic human breast tissues.
    Liapis H; Crouch EC; Grosso LE; Kitazawa S; Wick MR
    Am J Pathol; 1993 Oct; 143(4):1169-78. PubMed ID: 8214010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
    Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
    Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
    Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas.
    Shaw JA; Udokang K; Mosquera JM; Chauhan H; Jones JL; Walker RA
    J Pathol; 2002 Dec; 198(4):450-7. PubMed ID: 12434414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.
    Barbareschi M; Maisonneuve P; Aldovini D; Cangi MG; Pecciarini L; Angelo Mauri F; Veronese S; Caffo O; Lucenti A; Palma PD; Galligioni E; Doglioni C
    Cancer; 2003 Aug; 98(3):474-83. PubMed ID: 12879463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
    Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both human SP-A1 and Sp-A2 genes are expressed in small and large intestine.
    Lin Z; deMello D; Phelps DS; Koltun WA; Page M; Floros J
    Pediatr Pathol Mol Med; 2001; 20(5):367-86. PubMed ID: 11552738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of surfactant protein B precursor and surfactant protein B mRNA in adenocarcinoma of the lung.
    Khoor A; Whitsett JA; Stahlman MT; Halter SA
    Mod Pathol; 1997 Jan; 10(1):62-7. PubMed ID: 9021728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rudolf-Virchow-Preis 1996. Priesträgerrede. Detection of surfactant protein gene expression by reverse transcriptase-polymerase chain reaction (RT-PCR) identifies metastases and occult tumor spread of pulmonary adenocarcinomas.
    Papadopoulos T
    Verh Dtsch Ges Pathol; 1996; 80():LVII-LXI. PubMed ID: 9020567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid hydroperoxide glutathione peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma.
    Cejas P; García-Cabezas MA; Casado E; Belda-Iniesta C; De Castro J; Fresno JA; Sereno M; Barriuso J; Espinosa E; Zamora P; Feliu J; Redondo A; Hardisson DA; Renart J; González-Barón M
    Free Radic Res; 2007 Jun; 41(6):681-7. PubMed ID: 17516241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms.
    Lien HC; Lu YS; Cheng AL; Chang WC; Jeng YM; Kuo YH; Huang CS; Chang KJ; Yao YT
    J Pathol; 2006 Jul; 209(3):317-27. PubMed ID: 16639692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.
    Shibuya R; Suzuki T; Miki Y; Yoshida K; Moriya T; Ono K; Akahira J; Ishida T; Hirakawa H; Evans DB; Sasano H
    Endocr Relat Cancer; 2008 Mar; 15(1):113-24. PubMed ID: 18310280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minichromosome maintenance protein 2 is a reliable proliferative marker in breast carcinoma.
    Reena RM; Mastura M; Siti-Aishah MA; Munirah MA; Norlia A; Naqiyah I; Rohaizak M; Sharifah NA
    Ann Diagn Pathol; 2008 Oct; 12(5):340-3. PubMed ID: 18774496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
    Naidu R; Wahab NA; Yadav MM; Kutty MK
    Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.
    Stein T; Price KN; Morris JS; Heath VJ; Ferrier RK; Bell AK; Pringle MA; Villadsen R; Petersen OW; Sauter G; Bryson G; Mallon EA; Gusterson BA
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6872-9. PubMed ID: 16203777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.